David M. Max is a complex commercial litigator with a focus on securities and antitrust law, in matters before both federal and state courts. David has also worked on a variety of other litigation matters, covering contractual, employment, bankruptcy and professional malpractice issues, in sectors including the financial industry, cable television, pharmaceuticals, news media and energy.
- Teva Pharmaceuticals, and its US subsidiary Actavis, in defense of antitrust actions commenced by the State Attorneys General for 48 states, 28 civil antitrust class actions and multiple direct actions.
- Loreley Financing, a group of investment companies, in analyzing and bringing claims against several major investment banks and other financial institutions concerning billions of dollars of collateralized debt obligations and other structured finance products.
- Comcast Corporation in antitrust class actions brought on behalf of three putative classes each comprising approximately two million consumers.
- The Royal Bank of Canada in successful litigation concerning the waterfall provisions of certain RMBS.
- Hudson Solar Cayman as creditor in a dispute seeking payment by a public company pursuant to a guaranty on notes with a principal amount of approximately $54 million.
- A group of retail investors against Humanigen, a biopharmaceutical company engaged in Phase III clinical studies of its proprietary compound Lenzilumab, in a dispute alleging breach of contract relating to participation in a PIPE transaction in Humanigen.